Published October 6, 2016
| Published
Journal Article
Open
Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis
Abstract
All cellular proteins are synthesized by ribosomes, whose biogenesis in eukaryotes is a complex multi-step process completed within minutes. Several chemical inhibitors of ribosome function are available and used as tools or drugs. By contrast, we lack potent validated chemical probes to analyze the dynamics of eukaryotic ribosome assembly. Here, we combine chemical and genetic approaches to discover ribozinoindoles (or Rbins), potent and reversible triazinoindole-based inhibitors of eukaryotic ribosome biogenesis. Analyses of Rbin sensitivity and resistance conferring mutations in fission yeast, along with biochemical assays with recombinant proteins, provide evidence that Rbins’ physiological target is Midasin, an essential ∼540-kDa AAA+ (ATPases associated with diverse cellular activities) protein. Using Rbins to acutely inhibit or activate Midasin function, in parallel experiments with inhibitor-sensitive or inhibitor-resistant cells, we uncover Midasin’s role in assembling Nsa1 particles, nucleolar precursors of the 60S subunit. Together, our findings demonstrate that Rbins are powerful probes for eukaryotic ribosome assembly.
Copyright and License
© 2016 The Francis Crick Institute. Published by Elsevier under Creative Commons Attribution (CC BY 4.0).
Acknowledgement
We thank Hiro-oki Iwakawa and Yukihide Tomari for technical advice and help with northern blot experiments, Kuniko Saiki for help with northern blot experiments, Yoshinori Watanabe and Jun-ichi Nakayama for providing strains and plasmids, Akihisa Matsuyama and Minoru Yoshida for providing plasmids, Fraser Glickman for the use of the Rockefeller University High Throughput Screening Resource Center, Milica Tesic Mark from Rockefeller Proteomics Resource Center, Olivier Elemento for help with the bioinformatics analysis, Jonathan Steinman for help with analog synthesis, and Sebastian Klinge and Lisa Hang for valuable comments. This work was supported by JSPS KAKENHI Grant Number JP26711001 (to S.A.K.), Helen Hay Whitney Fellowship (to A.P.), the Breast Cancer Research Foundation (to P.N.), the Wellcome Trust (to P.N.), and the NIH/NIGMS GM98579 (to T.M.K.).
Contributions
S.A.K. and T.M.K. conceived and designed the project. S.A.K. performed most of the fission yeast experiments, except for construction and characterization of mdn1-ts26 mutant (by Y.A.) and of Mdn1 ATPase mutants (by Y.A. and Y.K.). Z.C. and A.P. synthesized Rbin-1 and analogs. Z.C. purified recombinant Mdn1 (wild-type and mutant) and carried out all the biochemical assays. P.N. advised on the chemical screen and yeast genetics. S.A.K., Z.C., and T.M.K. wrote the manuscript with contributions from all other authors.
Files
PIIS0092867416311680.pdf
Files
(5.6 MB)
Name | Size | Download all |
---|---|---|
md5:2b4a5b1c6a413fbda11bff5fb6f9fa71
|
5.6 MB | Preview Download |
md5:72760e2e29e167de6da435deb4a9821a
|
14.4 kB | Download |
md5:e0215ac6ae0b0611201c4489165d145b
|
11.4 kB | Download |
Additional details
- PMCID
- PMC5116814
- Japan Society for the Promotion of Science
- JP26711001
- Helen Hay Whitney Foundation
- Breast Cancer Research Foundation
- Wellcome Trust
- National Institutes of Health
- GM98579